Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.

Saved in:
Bibliographic Details
Title: Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.
Authors: Lee CL; Princess Margaret Cancer Center, University of Toronto, Toronto, ON M5G1Z5, Canada., Freeman M; Tom Baker Cancer Center, University of Calgary, Calgary, AB T2N4N2, Canada., Burak KW; Liver Unit, Divisions of Gastroenterology & Hepatology and Transplant Medicine, Departments of Medicine and Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N4N2, Canada., Moffat GT; Princess Margaret Cancer Center, University of Toronto, Toronto, ON M5G1Z5, Canada., O'Donnell CDJ; Juravinski Cancer Center, Escarpment Cancer Research Institute, McMaster University, Hamilton, ON L8S4L8, Canada., Ding PQ; Tom Baker Cancer Center, University of Calgary, Calgary, AB T2N4N2, Canada., Lyubetska H; CancerCare Manitoba, University of Manitoba, Winnipeg, MB R3A1R9, Canada., Meyers BM; Juravinski Cancer Center, Escarpment Cancer Research Institute, McMaster University, Hamilton, ON L8S4L8, Canada., Gordon V; CancerCare Manitoba, University of Manitoba, Winnipeg, MB R3A1R9, Canada., Kosyachkova E; Princess Margaret Cancer Center, University of Toronto, Toronto, ON M5G1Z5, Canada., Bucur R; Princess Margaret Cancer Center, University of Toronto, Toronto, ON M5G1Z5, Canada., Cheung WY; Tom Baker Cancer Center, University of Calgary, Calgary, AB T2N4N2, Canada., Knox JJ; Princess Margaret Cancer Center, University of Toronto, Toronto, ON M5G1Z5, Canada., Tam VC; Tom Baker Cancer Center, University of Calgary, Calgary, AB T2N4N2, Canada.
Source: Cancers [Cancers (Basel)] 2024 Aug 19; Vol. 16 (16). Date of Electronic Publication: 2024 Aug 19.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first